Abstract
We recently reported the urinary prostaglandin E2/creatinine ratio (PGE2/Cr) was markedly elevated in Hyp mice, the animal model for X-linked hypophosphatemia, compared with control mice. We provided evidence for altered prostaglandin production mediating the phosphaturia and that indomethacin decreases urinary phosphate excretion in Hyp mice but not control mice. To determine the levels of urinary PGE2/Cr, the safety and efficacy of indomethacin on phosphate excretion in children with hypophosphatemic rickets (HPR), a prospective clinical trial was performed in 16 children with HPR and 16 age- and gender-matched healthy controls. Urinary PGE2/Cr excretion was determined on a 24 h timed urine collection. A randomized cross over, placebo versus indomethacin, clinical trial was performed in the 16 children with HPR. There was no difference in urinary PGE2/Cr excretion between controls and patients with HPR. In children with HPR, indomethacin treatment for 3 mo had no significant effect on serum phosphorus or urinary phosphate excretion. In conclusion, urinary prostaglandin excretion is similar in children with HPR compared with controls. Indomethacin had no significant effect on serum phosphorus or urinary phosphate excretion in children with HPR.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- ADHR:
-
autosomal dominant hypophosphatemic rickets
- HPR:
-
hypophosphatemic rickets
- PGE2/Cr:
-
prostaglandin divided by urine creatinine
- TmP/GFR:
-
tubular maximum for the reabsorption of phosphate
- XLH:
-
X-linked hypophosphatemia
References
Rasmussen H, Tenehouse HS 1995 Mendelian hypophosphatemia. Scriver CR, Beaudet AL, Sly WS, Valle D The Metabolic Basis of Inherited Disease. New York McGraw-Hill pp 3717–3745
Holm IA, Huang X, Kunkel LM 1997 Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets. Am J Hum Genet 60: 790–797
Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs M, Lavigne J, Juppner H 2003 FGF 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348: 1656–1663
White KE, Jonsson KB, Carn G, Hampson G, Spector TD, Mannstadt M, Lorenz-Depiereux B, Miyauchi A, Yang IM, Ljunggren O, Meitinger T, Strom TM, Juppner H, Econs MJ 2001 The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide over-expressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab 86: 497–500
Shimada T, Muto T, Urakawa I, Yoneya T, Yamazaki Y, Okawa K, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T 2002 Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 143: 3179–3182
Baum M, Loleh S, Saini N, Seikaly M, Dwarakanath V, Quigley R 2003 Correction of proximal tubule phosphate transport defect in Hyp mice in vivo and in vitro with indomethacin. Proc Natl Acad Sci USA 100: 11098–11103
Syal A, Schiavi S, Chakravarty S, Dwarakanath V, Quigley R, Baum M 2006 Fibroblast growth factor-23 increases mouse PGE2 production in vivo and in vitro. Am J Physiol Renal Physiol 290: F450–F455
Seikaly MG, Browne RH, Baum M 1994 The effect of phosphate supplementation on linear growth in children with X-linked hypophosphatemia. Pediatrics 94: 478–481
Alon U, Hellerstein S 1994 Assessment and interpretation of tubular threshold for phosphate in infants and children. Pediatr Nephrol 8: 250–251
Choukair MK 2000 Blood chemistries/body fluids. Siberry GK, Iannone R The Harriet Lane Handbook. 15th ed. St. Louis Mosby pp 119–130
Schmitt CP, Mehls O 2004 The enigma of hyperparathyroidism in hypophosphatemic rickets. Pediatr Nephrol 19: 473–477
Seikaly M, Browne R, Baum M 1996 Nephrocalcinosis is associated with renal tubular acidosis in children with X-linked hypophosphatemia. Pediatrics 97: 91–93
Agnoli GC, Borgatti R, Cacciari M, Garutti C, Ikonomu E, Lenzi P, Marinelli M, Stipo L 1996 Responses of the renal prostanoids to a short-term depletion of sodium or potassium in healthy women. Boll Soc Ital Biol Sper 72: 109–116
Harris RC, Breyer MD 2001 Physiological regulation of cyclooxygenase-2 in the kidney. Am J Physiol Renal Physiol 281: F1–F11
Qi Z, Cai H, Morrow JD, Breyer MD 2006 Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aorta. Hypertension 48: 323–328
Schlondorff D 1986 Renal prostaglandin synthesis: sites of production and specific actions of prostaglandins. Am J Med 81: 1–11
Imbert-Teboul M, Siaume S, Morel F 1986 Sites of prostaglandin E2(PGE2) synthesis along the rabbit nephron. Mol Cell Endocrinol 45: 1–10
Liu S, Tang W, Zhou J, Stubbs JR, Lou Q, Pi M, Quarles DL 2006 Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17: 1305–1315
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was funded by an Institutional Grant from the Texas Scottish Rite Hospital for Children, Dallas, Texas (03–04-656 to M.S) and NIH (5R01- DK065842 to M. B.).
Rights and permissions
About this article
Cite this article
Seikaly, M., Waber, P. & Baum, M. Urinary Prostaglandins and the Effect of Indomethacin on Phosphate Excretion in Children With Hypophosphatemic Rickets. Pediatr Res 64, 210–212 (2008). https://doi.org/10.1203/PDR.0b013e318175d788
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/PDR.0b013e318175d788
This article is cited by
-
FGF23 and its role in X-linked hypophosphatemia-related morbidity
Orphanet Journal of Rare Diseases (2019)
-
Hypophosphatemia and growth
Pediatric Nephrology (2013)
-
Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets
Pediatric Nephrology (2011)
